Discover how data generated during patient care can be transformed into high-value assets to accelerate pharmaceutical research. In this webinar, we will explore how integrating the care pathway, pathology data, biobanking, and data structuring makes it possible to produce reliable, high-quality clinical datasets that are directly usable and aligned with the needs of pharmaceutical R&D.
Key Topics Include:
- Understand the full value chain of a clinical asset
- Identify the key stages that can impact the value of the final deliverable
- Assess the conditions required to produce a usable and research-ready dataset
Presenters
Nicolas Weinbreck
Dr. Nicolas Weinbreck is a pathologist and serves as Chief Executive Officer and Vice President of the Medipath Group. A recognized expert in anatomical and cytopathology, he specializes in soft tissue sarcomas. Strongly involved in issues related to quality, innovation, and the structuring of pathology practices in France, he also holds several national representative positions, notably within the CNPath and the SMPF. He regularly contributes to reference work, scientific publications, and educational activities dedicated to oncology and precision medicine.
Caroline Rancati
Caroline Rancati graduated with a Master's degree in biobanking and the use of associated data. She has been working in this field for 4 years specializing in the management and coordination of projects that require the sourcing of HBS and/or associated data.
Pauline Mespoulhé
Pauline Mespoulhé is a biobank and health data expert specializing in the valorization of human biological samples and their integration into innovative research projects. She supports biotech, pharma, medtech, and academic teams in ensuring scientific, regulatory, and strategic alignment to strengthen project quality and impact.
Sponsor
